TipRanks
Altimmune Inc (ALT)
NASDAQ:ALT
US Market
ALT
Altimmune
RESEARCH TOOLSreports
Want to see ALT full AI Analyst Report?

Altimmune (ALT) Stock News & Sentiment

3,802 Followers
Altimmune Draws New Loan Tranche to Extend Financing
Premium
Company Announcements
Altimmune Draws New Loan Tranche to Extend Financing
3d ago
8K
ALT
Altimmune refreshes board to support commercialization shift
Premium
Company Announcements
Altimmune refreshes board to support commercialization shift
5d ago
8K
ALT
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
Premium
Company Announcements
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
1M ago
8K
ALT
Altimmune’s Phase 3 MASH Trial Puts Pemvidutide in the Spotlight for Investors
Premium
Company Announcements
Altimmune’s Phase 3 MASH Trial Puts Pemvidutide in the Spotlight for Investors
1M ago
ALT
3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
Premium
Market News
3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
2M ago
ALT
KDK
Altimmune Charts Long Runway with Bold Trial Push
Premium
Company Announcements
Altimmune Charts Long Runway with Bold Trial Push
2M ago
ALT
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
Premium
Ratings
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
3M ago
ALT
More ALT News >

ALT News on the Web

Analysts Are Bullish on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Altimmune (ALT)
TipRanks News
Bullish
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
TipRanks News
Neutral
Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
Zacks
Neutral
Altimmune’s (ALT) Three Liver Trials Move Forward At Once
Insider Monkey
Neutral
3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
TipRanks News
Bullish
Altimmune's Phase III MASH Study Puts 2029 Data in Investor Focus
Zacks
Neutral
Is Altimmune Worth Buying as Cash Rises but Execution Risks Linger?
Zacks
Neutral
Cramer's lightning round: 'I'm going to say no' to United Microelectronics
CNBC
Bullish

News Score - Last 7 Days

Neutral
ALT
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALT’s Media Buzz Sentiment?
3 articles about ALT were published this week. In an average week, 1 articles are published.
    What is ALT’s weekly average amount of articles?
    In an average week, 1 articles about ALT are published.
      What is ALT’s News Sentiment?
      50% of articles about ALT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week